Home Infusion Therapy Market Size To Touch USD 65.2 Bn By 2030

Published Date : 27 Jan 2023

The global home infusion therapy market size was evaluated at USD 45.41 billion in 2022 and it is expected to touch around USD 65.2 billion by 2030, growing at a CAGR of 4.63% from 2022 to 2030.

When antibiotics are ineffective in treating a serious or persistent infection, infusion therapy is used. The treatment might be thought of as an alternative to oral medication. Cancers and the varied agony they bring as well as diarrhea, vomiting, dehydration, and complex disorders, are some of the main reasons. In the home infusion therapy method, patients are treated with biologics and medications at home. Medicines are administered with the help of needles and catheters. Patients are monitored closely by the service providers.

Report Highlights

The market for home infusion therapy is divided into categories grounded on the product, including intravenous sets, IV cannulas, infusion pumps, mobile infusion pumps, needleless connectors, and intravenous sets. The accessibility of a range of goods, such as an enteral, syringe, multichannel, and peristaltic pumps, also contributes to the segment's growth. 

In addition, the market has been divided into categories for specialized pharmaceuticals, enteral nutrition, chemotherapy, parenteral nutrition endocrinology, and anti-infectives based on application. This is explained by the large number of procedures used to administer antifungal & antibiotic medications.

Home Infusion Therapy Market Report Scope

Report Coverage Details
Market Size in 2022 USD 45.41 Billion
Market Size by 2030 USD 65.2 Billion
Growth Rate from 2022 to 2030 CAGR of 4.63%
Largest Market North America
Base Year 2022
Forecast Period 2022 to 2030
Segments Covered By Product, By Application, By Route of Administration, By End User
Regions Covered  North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Regional Snapshots

Due to its high rate of research and development activities, rising demand for long-term treatment for patients with certain conditions, adoption of new technology in infusion pumps, preference shift from acute care to home care settings because of lower costs and improved patient mobility, and development of alternative healthcare settings and home infusion services, North America dominates the global market for home infusion therapy. 

Since diabetes is becoming more common in the region and patients are becoming more aware of its advantages over hospital procedures, Asia-Pacific is predicted to have high growth rates between 2022 and 2030. The increasing prevalence of diabetes in the area and the increased patient awareness of the advantages of home infusion therapy versus hospital procedures are credited for this. 

The region's rising chronic disease rates and the aging population are predicted to contribute to the market's continued expansion. According to the Times of India, over 75 million Indians over the age of 60 have a chronic illness, which could lead to a rise in the demand for home care services.

Market Dynamics


The major factors propelling the growth of the home infusion therapy market are the rising demand for the therapy due to its affordability and patient-friendliness as well as the high utilization of the therapy for treating conditions like congestive heart failure, cancer, and immune deficiencies due to the use of oral medication. 

Because glutamine, phospholipids, and glucose are also added to the infusion to provide additional nutrition while administering medication, the increase in demand from patients needing long-term treatment and the rise in popularity of the therapy are factors that are accelerating the growth of the home infusion therapy market.

Furthermore, the market for home infusion therapy is also influenced by the increasing use of smart pumps, which have enhanced capabilities and offer accurate and controlled infusion rates. Additionally, the market for home infusion therapy is positively impacted by the growing elderly population and their lower mobility profiles, as well as by increased awareness, better healthcare infrastructure, and an increase in healthcare spending. Furthermore, during the projection period, participants in the home infusion treatment market will benefit from technical developments that improve the therapy's features.


On the other hand, a shortage of qualified medical personnel is expected to impede the market's expansion for home infusion therapy. Growing concerns about drug toxicity will hamper the adoption of this therapy and this kind of therapy becomes even more problematic when the treatment received by the patient is at home and such a workplace may not have all the equipment and medicines in place to tackle certain conditions. 

Another factor that is likely to hamper the growth of the market is the treatment of infectious diseases in the household. It increases the risk for other people even when utmost care is taken by the medical personnel.  During the projection period of 2022 to 2030, the market for home infusion therapy is expected to have difficulties due to a lack of knowledge.


The need for efficient home infusion devices and capabilities has risen due to the rising prevalence of hospitalization, which has fuelled demand in the worldwide home infusion treatment market. The growing prevalence of the diseases like ulcerative colitis and Crohn's disease will provide growth opportunities for the home infusion therapy market in the North American region. Home infusion therapies are preferred by millions of adults suffering from asthma as the use of these therapies provides cost-effective treatment. Cancer, chronic obstructive pulmonary disease, and asthma are some of the diseases that have increased in recent times creating more demand for home infusion therapy.  


One of the most frequently prescribed home infusion therapies is anti-infective therapy. A team approach, along with strict patient selection criteria, an organized follow-up process, and a focus on patient education can mitigate the few hazards that are inherent to this type of therapy. Increased complications and safety concerns associated with this therapy may have a negative effect on market growth. Infusion sets could suffer from damaged parts, software defects battery failure, and inadequate design of the user interface. 

All of these are seen to be the major challenges in the work of the market. The scenario of the reimbursement policies is not very favorable, and this will also hamper the market growth. There are also many difficulties faced by the caregivers due to the unfamiliar settings present in the household. All these factors create resistance to this kind of treatment among patients. 

Recent Developments

  • In March 2021, NBN Infusions, Inc., a New Jersey-based supplier of home infusion and respiratory therapy services, was acquired by PromptCare. NBN Infusions, Inc. specializes in giving critically ill patients infusion therapy. Through this deal, PromptCare will increase its market share in the Northeastern U.S.
  • In January 2021 - To provide COVID-19 infusion therapy to the vulnerable population, Amedisys worked with Option Care Health.

Major Key Players:

  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat (UnitedHealth Optum)
  • PharMerica
  • Fresenius Kabi
  • ICU Medical, Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smith’s Medical
  • Terumo Corporation
  • JMS Co. Ltd.
  • Others 

Market Segmentation:

By Product

  • Infusion Pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors 

By Application

  • Anti-infective
  • Endocrinology
  • Diabetes
  • Others
  • Hydration Therapy
  • Athletes
  • Others
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Others

By Route of Administration

  • Intramuscular
  • Subcutaneously
  • Epidural

By End User

  • Patients
  • Nurse
  • Hospitals
  • Others 

Buy this Research Report@ https://www.precedenceresearch.com/checkout/2012

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com| +1 9197 992 333